Qualitative or quantitative defects of emerin

Qualitative or quantitative defects of emerin refers to a group of conditions caused by mutations in the EMD gene (also known as STA), which encodes the nuclear envelope protein emerin. This condition is most commonly associated with Emery-Dreifuss muscular dystrophy (EDMD), specifically the X-linked form (X-linked EDMD, EDMD1). Emerin is a protein located at the inner nuclear membrane of most cells, and its deficiency or dysfunction leads to progressive skeletal muscle weakness and wasting, joint contractures, and cardiac disease. The disease primarily affects the musculoskeletal and cardiovascular systems. The classic clinical triad includes early contractures of the elbows, Achilles tendons, and posterior cervical muscles; slowly progressive muscle weakness and wasting initially in a humeroperoneal distribution (upper arms and lower legs); and cardiac conduction defects with cardiomyopathy. Joint contractures often appear in early childhood, preceding significant muscle weakness. Cardiac involvement typically manifests in the second to third decade of life and can include atrial arrhythmias, atrioventricular block, and dilated cardiomyopathy. Cardiac complications are potentially life-threatening and may require pacemaker or implantable cardioverter-defibrillator placement. Female carriers may also develop cardiac conduction abnormalities later in life. There is currently no cure for emerin deficiency. Treatment is supportive and multidisciplinary, focusing on management of contractures through physical therapy and orthopedic interventions, cardiac monitoring with timely insertion of pacemakers or defibrillators to prevent sudden cardiac death, and management of heart failure when present. Regular cardiac surveillance is essential for both affected males and female carriers. Genetic counseling is recommended for affected families.

Common questions about Qualitative or quantitative defects of emerin